Minerva Neurosciences Company Insiders

Minerva Neurosciences Management Team Effectiveness

The company has return on total asset (ROA) of (0.2582) % which means that it has lost $0.2582 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (6.7509) %, meaning that it created substantial loss on money invested by shareholders. Minerva Neurosciences' management efficiency ratios could be used to measure how well Minerva Neurosciences manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Minerva Neurosciences' Return On Tangible Assets are fairly stable compared to the past year. Return On Assets is likely to climb to 0.04 in 2026, whereas Return On Capital Employed is likely to drop (0.60) in 2026. At this time, Minerva Neurosciences' Total Assets are fairly stable compared to the past year. Other Current Assets is likely to climb to about 1.5 M in 2026, whereas Other Assets are likely to drop 0.86 in 2026. Common Stock Shares Outstanding is likely to drop to about 4.7 M in 2026. Net Loss is likely to drop to about (38.8 M) in 2026The market capitalization of Minerva Neurosciences is $26.92 Million. Minerva Neurosciences holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run. Some institutional investors establish a significant position in stocks such as Minerva Neurosciences in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Minerva Neurosciences, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Minerva Neurosciences Workforce Comparison

Minerva Neurosciences Insider Trading History

Minerva Neurosciences Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Minerva Neurosciences often depends on how effective the management is. Minerva Neurosciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Minerva management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Minerva management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Minerva Neurosciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Minerva Neurosciences. Check Minerva Neurosciences' Beneish M Score to see the likelihood of Minerva Neurosciences' management manipulating its earnings.

When running Minerva Neurosciences' price analysis, check to measure Minerva Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Minerva Neurosciences is operating at the current time. Most of Minerva Neurosciences' value examination focuses on studying past and present price action to predict the probability of Minerva Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Minerva Neurosciences' price. Additionally, you may evaluate how the addition of Minerva Neurosciences to your portfolios can decrease your overall portfolio volatility.